- Home
- GNW vs CRNX Comparison
GNW vs CRNX Comparison
Compare GNW & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GNW | CRNX |
|---|---|---|
| Founded | 1871 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 4.1B |
| IPO Year | 2004 | 2018 |
Fundamental Metrics
Financial Performance| Metric | GNW | CRNX |
|---|---|---|
| Price | $8.52 | $55.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 11 |
| Target Price | $10.00 | ★ $73.70 |
| AVG Volume (30 Days) | ★ 3.9M | 1.6M |
| Earning Date | 02-23-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 160.86 | N/A |
| EPS | ★ 0.52 | N/A |
| Revenue | ★ $7,299,000,000.00 | $1,535,000.00 |
| Revenue This Year | N/A | $425.41 |
| Revenue Next Year | N/A | $943.30 |
| P/E Ratio | $14.47 | ★ N/A |
| Revenue Growth | N/A | ★ 47.74 |
| 52 Week Low | $5.99 | $24.10 |
| 52 Week High | $9.28 | $57.99 |
Technical Indicators
Market Signals| Indicator | GNW | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 36.29 | 66.09 |
| Support Level | $8.41 | $53.45 |
| Resistance Level | $9.12 | $56.23 |
| Average True Range (ATR) | 0.19 | 2.97 |
| MACD | -0.08 | 0.60 |
| Stochastic Oscillator | 12.18 | 81.08 |
Price Performance
Historical ComparisonAbout GNW Genworth Financial Inc
Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, Life and Annuities segment and Long-Term Care Insurance. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. Majority of the revenue is generated by the Enact segment. The company earns maximum of its revenue in the United States.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.